Melanotan I and PT-141 Interaction

Monitor
Mechanism-based 55% confidence

Melanotan I and PT-141 have an interaction requiring monitoring for interaction with 55% confidence. Both Melanotan I and PT-141 activate melanocortin receptors. Additive effects may increase nausea, flushing, and appetite suppression. Use lower doses of each if combining. These compounds primarily affect different organ systems.

Compound Profiles

Melanotan I

Melanocortin Receptor Agonist

Subcutaneous injection delivers peptide directly into systemic circulation. Selectively activates MC1R receptors to stimulate melanin production.

Half-life: ~30 minutes Typical dose: Loading: 0.25-0.5mg daily; Maintenance: 0.25-0.5mg 2-3x weekly skin
melanocortin receptor
View full profile

PT-141

Melanocortin Receptor Agonist | Sexual Dysfunction Treatment

Selectively activates melanocortin receptors (MC3R/MC4R) in the central nervous system, triggering sexual arousal pathways independent of peripheral vascular mechanisms. Works within 45 minutes with effects lasting 6-12 hours.

Half-life: ~2.7 hours Typical dose: Women: 1.75mg (FDA-approved); Men: 1-2mg; Start 0.5mg test dose for tolerance sexual health
melanocortin receptor blood pressure raisingteratogenic
View full profile

Combined Organ Load

Skin
low
Gonads
low

Frequently Asked Questions

Can I take Melanotan I with PT-141?

Yes, but with caution. Both Melanotan I and PT-141 activate melanocortin receptors. Additive effects may increase nausea, flushing, and appetite suppression. Use lower doses of each if combining. Regular monitoring is advised.

Is Melanotan I and PT-141 safe together?

Based on pharmacological analysis, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between Melanotan I and PT-141?

Both Melanotan I and PT-141 activate melanocortin receptors. Additive effects may increase nausea, flushing, and appetite suppression. Use lower doses of each if combining. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time Melanotan I and PT-141?

Melanotan I has a half-life of ~30 minutes and PT-141 has a half-life of ~2.7 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Melanotan I vs PT-141

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.